Cathay Historical Income Statement
| 688065 Stock | 42.84 0.22 0.51% |
Historical analysis of Cathay Biotech income statement accounts such as Net Interest Income of 134.7 M, Interest Income of 156.9 M or Interest Expense of 19.7 M can show how well Cathay Biotech performed in making a profits. Evaluating Cathay Biotech income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Cathay Biotech's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Cathay Biotech latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cathay Biotech is a good buy for the upcoming year.
Cathay |
About Cathay Income Statement Analysis
Cathay Biotech Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Cathay Biotech shareholders. The income statement also shows Cathay investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Cathay Biotech Income Statement Chart
Tax Provision
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.Net Interest Income
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Cathay Biotech financial statement analysis. It represents the amount of money remaining after all of Cathay Biotech operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Cathay Biotech's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Cathay Biotech current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cathay Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Cathay Biotech's Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 2.3 B, whereas Net Interest Income is forecasted to decline to about 134.7 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 16.3M | 20.0M | 32.2M | 19.7M | Interest Income | 213.3M | 236.8M | 219.8M | 156.9M |
Cathay Biotech income statement Correlations
Click cells to compare fundamentals
Cathay Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Currently Active Assets on Macroaxis
Other Information on Investing in Cathay Stock
Cathay Biotech Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Cathay Biotech shareholders. The income statement also shows Cathay investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).